Market Cap 2.34M
Revenue (ttm) 43.79M
Net Income (ttm) -37.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -85.36%
Debt to Equity Ratio -1.50
Volume 262,100
Avg Vol 112,938
Day's Range N/A - N/A
Shares Out 3.59M
Stochastic %K 9%
Beta N/A
Analysts Strong Buy
Price Target $15.00

Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mump...

Industry: Medical Devices
Sector: Healthcare
Phone: 353 1 276 9800
Fax: 353 1 276 9888
Address:
IDA Business Park, Bray, Ireland
deepthinker
deepthinker Jun. 13 at 8:52 PM
0 · Reply
Clydagh
Clydagh Jun. 11 at 11:49 AM
$TRIB SEC has filed "EFFECT" so Yorkville may now be used. Trib will have known yesterday so it seems today is not the big day. Mondays and Tuesdays best for big news that needs a decent SP run.
0 · Reply
Super5Investments
Super5Investments Jun. 11 at 2:29 AM
$TRIB Perceptive is the only winner regardless of Trinitys successes and failures. They are funded by Trinitys common shareholders . Investors beware. Stay away from this one. History tells the story.
1 · Reply
deepthinker
deepthinker Jun. 6 at 11:22 PM
$TRIB If they had a device which measured glucose and troponin, that would be epic. They have a troponin test which failed for hospital use, but might be repurposed as a consumer test. Crazy?
0 · Reply
Clydagh
Clydagh Jun. 6 at 1:13 PM
$TRIB another filing late friday to clarify legalities before raising cash. A waiver from Perceptive on minimum cash. Tells us Trib is broke again but more importantly it only last for the month of June. Three guesses as to what happens in June 1 Bayer 2 Sensor deal for insulin pump manufacturer 3 Both of the above
2 · Reply
deepthinker
deepthinker Jun. 5 at 11:05 PM
$TRIB Perceptive has stuck with Gillard and the CGM plan for 30 months now. They will change managements, boards, and dictate that companies be sold when things have gone south. Haven’t done any such thing here. Yet.
0 · Reply
deepthinker
deepthinker Jun. 5 at 9:45 PM
$TRIB Perceptive continues to float them. Did so again in May. This can’t go on forever, I wouldn’t think.
0 · Reply
Clydagh
Clydagh Jun. 5 at 8:10 AM
$TRIB Trib made an error on the Jan 3 filing and corrected on Jan 4. They are in a hurry....to raise cash. The bull view is that raise is after big news. the bear view is just dilution. Obviously I am in the bull camp. the corrected filing should take less time for an SEC decision...maybe as soon as today or monday as its a simple amendment to a previously signed off filing.
1 · Reply
deepthinker
deepthinker Jun. 4 at 8:32 PM
$TRIB On a serious note. Let’s say there was a partner. The partner could buy some of Perceptive’s stock now that it can be converted. That would reduce debt. The partner could also buy via the SEPA, which would provide liquidity for upcoming trials. Interesting that the ADA meeting starts in 2 days. Trinity hasn’t mentioned it.
1 · Reply
deepthinker
deepthinker Jun. 4 at 8:24 PM
$TRIB Carter Ledyard doesn’t seem to know their SEC forms. Might want to invest in AI. The law can be tough.🤣
0 · Reply
Latest News on TRIB
Trinity Biotech Registration statement: Registration filing

Jun 3, 2026, 8:00 AM EDT - 12 days ago

Trinity Biotech Registration statement: Registration filing


Trinity Biotech Registration statement: Registration filing

May 13, 2026, 8:00 AM EDT - 4 weeks ago

Trinity Biotech Registration statement: Registration filing


Trinity Biotech Registration statement: Registration filing

May 13, 2026, 8:00 AM EDT - 4 weeks ago

Trinity Biotech Registration statement: Registration filing


Trinity Biotech Annual report: Q4 2025

Apr 30, 2026, 7:00 AM EDT - 6 weeks ago

Trinity Biotech Annual report: Q4 2025


Trinity Biotech Slides: Q4 2025

Apr 30, 2026, 7:00 AM EDT - 6 weeks ago

Trinity Biotech Slides: Q4 2025


Trinity Biotech Provides Business and Trading Update

Mar 10, 2026, 7:45 AM EDT - 3 months ago

Trinity Biotech Provides Business and Trading Update


Trinity Biotech secures $25M standby equity purchase agreement

2026-02-25T14:14:32.000Z - 3 months ago

Trinity Biotech secures $25M standby equity purchase agreement


Trinity Biotech Registration statement: Registration filing

Feb 25, 2026, 7:00 AM EST - 3 months ago

Trinity Biotech Registration statement: Registration filing


Trinity Biotech receives noncompliance notification from Nasdaq

2026-02-20T22:10:49.000Z - 4 months ago

Trinity Biotech receives noncompliance notification from Nasdaq


Trinity Biotech receives noncompliance notification from Nasdaq

2026-02-13T22:10:18.000Z - 4 months ago

Trinity Biotech receives noncompliance notification from Nasdaq


Trinity Biotech files to sell 55.89M American depositary shares

2026-01-15T21:35:23.000Z - 5 months ago

Trinity Biotech files to sell 55.89M American depositary shares


Trinity Biotech Slides: Q3 2025

Dec 23, 2025, 9:30 AM EST - 6 months ago

Trinity Biotech Slides: Q3 2025


Trinity Biotech Slides: Q2 2025

Dec 23, 2025, 8:30 AM EST - 6 months ago

Trinity Biotech Slides: Q2 2025


Trinity Biotech appoints Paul Murphy as interim CFO

2025-12-23T12:40:40.000Z - 6 months ago

Trinity Biotech appoints Paul Murphy as interim CFO


Trinity Biotech awarded order for 9M TrinScreen HIV tests

2025-12-23T12:35:24.000Z - 6 months ago

Trinity Biotech awarded order for 9M TrinScreen HIV tests


Trinity Biotech Appoints Paul Tivnan as Non-Executive Director

Aug 21, 2025, 9:00 AM EDT - 10 months ago

Trinity Biotech Appoints Paul Tivnan as Non-Executive Director


Trinity Biotech Slides: Q1 2025

Jul 1, 2025, 7:00 AM EDT - 1 year ago

Trinity Biotech Slides: Q1 2025


Trinity Biotech Earnings release: Q4 2024

May 16, 2025, 6:00 AM EDT - 1 year ago

Trinity Biotech Earnings release: Q4 2024


Trinity Biotech Annual report: Q4 2024

May 16, 2025, 6:00 AM EDT - 1 year ago

Trinity Biotech Annual report: Q4 2024


Trinity Biotech Registration statement: Registration Filing

Mar 21, 2025, 8:00 AM EDT - 1 year ago

Trinity Biotech Registration statement: Registration Filing


Trinity Biotech Registration statement: Registration Filing

Nov 29, 2024, 7:00 AM EST - 1 year ago

Trinity Biotech Registration statement: Registration Filing


Trinity Biotech Earnings Call Transcript: Q3 2024

Nov 15, 2024, 10:00 AM EST - 1 year ago

Trinity Biotech Earnings Call Transcript: Q3 2024


Trinity Biotech Earnings release: Q3 2024

Nov 15, 2024, 10:00 AM EST - 1 year ago

Trinity Biotech Earnings release: Q3 2024


Trinity Biotech Announces Q3 2024 Financial Results

Nov 15, 2024, 9:00 AM EST - 1 year ago

Trinity Biotech Announces Q3 2024 Financial Results


Trinity Biotech Registration statement: Registration Filing

Nov 15, 2024, 7:00 AM EST - 1 year ago

Trinity Biotech Registration statement: Registration Filing


Trinity Biotech to Announce Q3 2024 Financial Results

Nov 14, 2024, 8:07 AM EST - 1 year ago

Trinity Biotech to Announce Q3 2024 Financial Results


Trinity Biotech Earnings Call Transcript: Q2 2024

Aug 14, 2024, 8:30 AM EDT - 1 year ago

Trinity Biotech Earnings Call Transcript: Q2 2024


Trinity Biotech Earnings release: Q2 2024

Aug 14, 2024, 8:30 AM EDT - 1 year ago

Trinity Biotech Earnings release: Q2 2024


Trinity Biotech Announces Q2 2024 Financial Results

Aug 14, 2024, 7:30 AM EDT - 1 year ago

Trinity Biotech Announces Q2 2024 Financial Results


Trinity Biotech to Announce Q2 2024 Financial Results

Aug 13, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech to Announce Q2 2024 Financial Results


deepthinker
deepthinker Jun. 13 at 8:52 PM
0 · Reply
Clydagh
Clydagh Jun. 11 at 11:49 AM
$TRIB SEC has filed "EFFECT" so Yorkville may now be used. Trib will have known yesterday so it seems today is not the big day. Mondays and Tuesdays best for big news that needs a decent SP run.
0 · Reply
Super5Investments
Super5Investments Jun. 11 at 2:29 AM
$TRIB Perceptive is the only winner regardless of Trinitys successes and failures. They are funded by Trinitys common shareholders . Investors beware. Stay away from this one. History tells the story.
1 · Reply
deepthinker
deepthinker Jun. 6 at 11:22 PM
$TRIB If they had a device which measured glucose and troponin, that would be epic. They have a troponin test which failed for hospital use, but might be repurposed as a consumer test. Crazy?
0 · Reply
Clydagh
Clydagh Jun. 6 at 1:13 PM
$TRIB another filing late friday to clarify legalities before raising cash. A waiver from Perceptive on minimum cash. Tells us Trib is broke again but more importantly it only last for the month of June. Three guesses as to what happens in June 1 Bayer 2 Sensor deal for insulin pump manufacturer 3 Both of the above
2 · Reply
deepthinker
deepthinker Jun. 5 at 11:05 PM
$TRIB Perceptive has stuck with Gillard and the CGM plan for 30 months now. They will change managements, boards, and dictate that companies be sold when things have gone south. Haven’t done any such thing here. Yet.
0 · Reply
deepthinker
deepthinker Jun. 5 at 9:45 PM
$TRIB Perceptive continues to float them. Did so again in May. This can’t go on forever, I wouldn’t think.
0 · Reply
Clydagh
Clydagh Jun. 5 at 8:10 AM
$TRIB Trib made an error on the Jan 3 filing and corrected on Jan 4. They are in a hurry....to raise cash. The bull view is that raise is after big news. the bear view is just dilution. Obviously I am in the bull camp. the corrected filing should take less time for an SEC decision...maybe as soon as today or monday as its a simple amendment to a previously signed off filing.
1 · Reply
deepthinker
deepthinker Jun. 4 at 8:32 PM
$TRIB On a serious note. Let’s say there was a partner. The partner could buy some of Perceptive’s stock now that it can be converted. That would reduce debt. The partner could also buy via the SEPA, which would provide liquidity for upcoming trials. Interesting that the ADA meeting starts in 2 days. Trinity hasn’t mentioned it.
1 · Reply
deepthinker
deepthinker Jun. 4 at 8:24 PM
$TRIB Carter Ledyard doesn’t seem to know their SEC forms. Might want to invest in AI. The law can be tough.🤣
0 · Reply
Clydagh
Clydagh Jun. 4 at 12:03 PM
$TRIB In my mind, the interesting reveal from the new filing is that the $2.5M cash injection on April did not just increase debt by $2.5M. Another $5M of unpaid interest was added to the total. So Trib is not paying interest yet the $5M they got on Dec 20 and another $0.8M raised in March was gone by April 30 despite improved operational cash flow. Gillard the cost-cutter is spending on something like money is going out of fashion and Perceptive is backing more heavily than ever. Oh and total debt has now reached $135M.
1 · Reply
deepthinker
deepthinker Jun. 3 at 10:03 PM
$TRIB OK, so why are they doing all the fancy footwork on the SEC forms?
1 · Reply
ryan2019
ryan2019 Jun. 1 at 7:44 PM
$TRIB On May 27, I said the Perceptive overhang didn’t remove the risk — it finally defined it. Now the setup is starting to align. CGM+ is the prize. PulseAI adds the AI/multi-signal wearable angle. Yorkville gives funding flexibility. Perceptive cleanup gets much cleaner at higher VWAP. Bayer/China/India still matter. The market sees dilution. I see dilution price being the key. At $1 = fear. At $3$5 = a completely different balance sheet story. One real CGM+ / FDA / partner update and this can wake up fast. Risk is real, but the upside setup finally looks aligned. Buckle up — this ride could finally be getting started. $TRIB
1 · Reply
Clydagh
Clydagh Jun. 1 at 7:08 AM
$TRIB Following the money. Dec 20 Trib got $5M Dec 31 Trib reported just $5.138M cash. Yikes! Companies max reported cash - paying the bills on Jan 2. Cash clearly extremely tight with no buffers. Apr 30 Trib got $2.5M but were forced to make an emergency draw of $0.87M from Yorkville beforehand. So 4mth burn of $5.87M. How long does the new $2.5M last. End-June? The (slightly rushed?) filings have put everything in place to instantly capitalise on a sudden share price jump. On top of that we have a new website ready to launch - I am guessing that's a corporate re-branding as a wearable biosensor company. They would have held off on the recent filings if more cash was coming from Perceptive. Something has to give. Feels like June is the month. Trib need a 4-5 day share price run for Yorkville to work. Watch for Monday or Tuesday pre-market PRs. Fridays PRs are for bad news, Thursday not much better. I'm guessing June 8/9 or 15/16 but could be as early as today.
0 · Reply
Super5Investments
Super5Investments May. 31 at 6:08 AM
$TRIB Other Emerging Tech on the Horizon: Fully Needle-Free & Multi-Analyte Patches: Surface-level micromedical wearables are in development to monitor glucose alongside lactate and stress hormones without breaking the skin
0 · Reply
Super5Investments
Super5Investments May. 31 at 6:06 AM
$TRIB "Emerging Tech on the HorizonFully Internal Bluetooth Implants: Next-gen designs from companies like Glucotrack (targeting a 3-year lifespan) and Senseonics aim to build Bluetooth directly inside the internal sensor. This completely eliminates the need for an on-body external transmitter patch."
0 · Reply
Super5Investments
Super5Investments May. 31 at 6:05 AM
$TRIB "The Dexcom G8 is the next state-of-the-art continuous glucose monitor (CGM). Unveiled by Dexcom in May 2026, the G8 is built on an entirely new silicon chip architecture and adaptive sensing algorithm to heavily reduce outlier readings. Alongside this breakthrough, the industry is transitioning toward 15-day wear cycles, dual-analyte sensors (tracking glucose and ketones), and ultra-long-lasting implantable devices"
0 · Reply
deepthinker
deepthinker May. 28 at 3:18 PM
$TRIB I would hope that these guys would have at least investigated the possibility of a consumer grade troponin test/sensor based on Meritas. Maybe it’s technically impossible. IDK.
1 · Reply
Clydagh
Clydagh May. 28 at 2:27 PM
$TRIB SEC filings are formal legal docs and as such every word is checked by the lawyers. Interesting then that Trinity describes itself as "a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors" that intends to develop "a range of biosensor devices and related services, starting with a continuous glucose monitoring product." For those who think its all fake news.
1 · Reply
Think_Bigly
Think_Bigly May. 27 at 7:59 PM
$TRIB to ABT: @ $90M
0 · Reply
ryan2019
ryan2019 May. 27 at 6:04 PM
$TRIB On May 6, I said the question was whether $TRIB was the same old story or the start of a real turnaround. Now the Perceptive filing is out. Dilution risk is real — but the overhang is finally visible. That makes the next catalyst huge. CGM+. Bayer/China/India. Pivotal trial. Funding. Debt cleanup. Revenue improvement. Any real update now could change the entire setup. Higher VWAP + stronger volume = less dilution pressure and a cleaner path forward. The market sees dilution. I see the overhang finally defined — and the next move now matters more than ever. Risk is on the table. So is the upside. Known overhang. Catalyst window open. CGM+ still the wildcard.💰
1 · Reply
deepthinker
deepthinker May. 26 at 6:18 PM
$TRIB There’s a good chance Jeon is speaking with Perceptive here. Komico just issued a 50% dividend, so he’s very liquid.
0 · Reply